In our study, keratin 18 showed greater abundance in GI compared to control and GII, thus suggesting it as a potential regulator of the tumor growth process, since studies indicate that a lower abundance of this protein in patients with cancer in advanced stages is related to greater tumor invasiveness and consequently a worse prognosis [78]. This evidence concerns the gene KRT18 and cancer.